201 related articles for article (PubMed ID: 37298437)
1. Δ
Anchesi I; Schepici G; Chiricosta L; Gugliandolo A; Salamone S; Caprioglio D; Pollastro F; Mazzon E
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298437
[TBL] [Abstract][Full Text] [Related]
2. Effects on variable-interval performance in rats of delta 9-tetrahydrocannabinol and cannabidiol, separately and in combination.
Zuardi AW; Karniol IG
Braz J Med Biol Res; 1983 Jul; 16(2):141-6. PubMed ID: 6317104
[TBL] [Abstract][Full Text] [Related]
3. Using the BMD Approach to Derive Acceptable Daily Intakes of Cannabidiol (CBD) and Tetrahydrocannabinol (THC) Relevant to Electronic Cigarette Liquids.
Hindelang P; Scharinger A; Richling E; Walch SG; Lachenmeier DW
Front Biosci (Landmark Ed); 2022 Jul; 27(8):228. PubMed ID: 36042166
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoids Alleviate the LPS-Induced Cytokine Storm via Attenuating NLRP3 Inflammasome Signaling and TYK2-Mediated STAT3 Signaling Pathways In Vitro.
Suryavanshi SV; Zaiachuk M; Pryimak N; Kovalchuk I; Kovalchuk O
Cells; 2022 Apr; 11(9):. PubMed ID: 35563697
[TBL] [Abstract][Full Text] [Related]
5. Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L.
El-Alfy AT; Ivey K; Robinson K; Ahmed S; Radwan M; Slade D; Khan I; ElSohly M; Ross S
Pharmacol Biochem Behav; 2010 Jun; 95(4):434-42. PubMed ID: 20332000
[TBL] [Abstract][Full Text] [Related]
6. Effects of marihuana cannabinoids on seizure activity in cobalt-epileptic rats.
Colasanti BK; Lindamood C; Craig CR
Pharmacol Biochem Behav; 1982 Apr; 16(4):573-8. PubMed ID: 6280204
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoids Delta(9)-tetrahydrocannabinol and cannabidiol differentially inhibit the lipopolysaccharide-activated NF-kappaB and interferon-beta/STAT proinflammatory pathways in BV-2 microglial cells.
Kozela E; Pietr M; Juknat A; Rimmerman N; Levy R; Vogel Z
J Biol Chem; 2010 Jan; 285(3):1616-26. PubMed ID: 19910459
[TBL] [Abstract][Full Text] [Related]
8. Δ⁹-tetrahydrocannabinol (Δ⁹-THC) exerts a direct neuroprotective effect in a human cell culture model of Parkinson's disease.
Carroll CB; Zeissler ML; Hanemann CO; Zajicek JP
Neuropathol Appl Neurobiol; 2012 Oct; 38(6):535-47. PubMed ID: 22236282
[TBL] [Abstract][Full Text] [Related]
9. Effects of delta-9-tetrahydrocannabinol, 11-hydroxy-delta-9-tetrahydrocannabinol and cannabidiol on neuromuscular transmission in the frog.
Turkanis SA; Karler R
Neuropharmacology; 1986 Nov; 25(11):1273-8. PubMed ID: 3025765
[TBL] [Abstract][Full Text] [Related]
10. Effects of delta 9-tetrahydrocannabinol and cannabidiol on phospholipase and other enzymes regulating arachidonate metabolism.
White HL; Tansik RL
Prostaglandins Med; 1980 Jun; 4(6):409-17. PubMed ID: 6251493
[TBL] [Abstract][Full Text] [Related]
11. Receptor-mediated effects of Δ
Preteroti MW; Traboulsi H; Greiss P; Lapohos O; Fonseca GJ; Eidelman DH; Baglole CJ
Immunol Cell Biol; 2023 Feb; 101(2):156-170. PubMed ID: 36510483
[TBL] [Abstract][Full Text] [Related]
12. Differential transcriptional profiles mediated by exposure to the cannabinoids cannabidiol and Δ9-tetrahydrocannabinol in BV-2 microglial cells.
Juknat A; Pietr M; Kozela E; Rimmerman N; Levy R; Coppola G; Geschwind D; Vogel Z
Br J Pharmacol; 2012 Apr; 165(8):2512-28. PubMed ID: 21542829
[TBL] [Abstract][Full Text] [Related]
13. Acute effects of Δ
Greenwood LM; Broyd SJ; van Hell HH; Todd J; Jones A; Murray RM; Croft RJ; Michie PT; Solowij N
Psychopharmacology (Berl); 2022 May; 239(5):1409-1424. PubMed ID: 34719731
[TBL] [Abstract][Full Text] [Related]
14. Cannabidiol Counteracts the Psychotropic Side-Effects of Δ-9-Tetrahydrocannabinol in the Ventral Hippocampus through Bidirectional Control of ERK1-2 Phosphorylation.
Hudson R; Renard J; Norris C; Rushlow WJ; Laviolette SR
J Neurosci; 2019 Oct; 39(44):8762-8777. PubMed ID: 31570536
[TBL] [Abstract][Full Text] [Related]
15. The effects of delta 9-tetrahydrocannabinol alone and in combination with cannabidiol on fixed-interval performance in rhesus monkeys.
Brady KT; Balster RL
Psychopharmacology (Berl); 1980; 72(1):21-6. PubMed ID: 6258188
[TBL] [Abstract][Full Text] [Related]
16. Interactions between delta 9-tetrahydrocannabinol and cannabidiol as evaluated by drug discrimination procedures in rats and pigeons.
Hiltunen AJ; Järbe TU
Neuropharmacology; 1986 Feb; 25(2):133-42. PubMed ID: 3010159
[TBL] [Abstract][Full Text] [Related]
17. Individual and combined effects of cannabidiol and Δ
Wall MB; Freeman TP; Hindocha C; Demetriou L; Ertl N; Freeman AM; Jones AP; Lawn W; Pope R; Mokrysz C; Solomons D; Statton B; Walker HR; Yamamori Y; Yang Z; Yim JL; Nutt DJ; Howes OD; Curran HV; Bloomfield MA
J Psychopharmacol; 2022 Jun; 36(6):732-744. PubMed ID: 35596578
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological interaction of the effects of delta 9-trans-tetrahydrocannabinol and cannabidiol on serum corticosterone levels in rats.
Zuardi AW; Teixeira NA; Karniol IC
Arch Int Pharmacodyn Ther; 1984 May; 269(1):12-9. PubMed ID: 6087750
[TBL] [Abstract][Full Text] [Related]
19. Psychomotor performance in relation to acute oral administration of Delta9-tetrahydrocannabinol and standardized cannabis extract in healthy human subjects.
Roser P; Gallinat J; Weinberg G; Juckel G; Gorynia I; Stadelmann AM
Eur Arch Psychiatry Clin Neurosci; 2009 Aug; 259(5):284-92. PubMed ID: 19224107
[TBL] [Abstract][Full Text] [Related]
20. A Critical Review of the Role of the Cannabinoid Compounds Δ
Jones É; Vlachou S
Molecules; 2020 Oct; 25(21):. PubMed ID: 33113776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
